2019
DOI: 10.1016/j.nicl.2019.102056
|View full text |Cite
|
Sign up to set email alerts
|

Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment

Abstract: HighlightsFrontal alpha asymmetry (FAA) is moderately stable over time.Antidepressant response prediction with FAA remains consistent, even after 8 weeks of treatment.FAA is a differential predictor of antidepressant response robust to state and drug effects.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(29 citation statements)
references
References 38 publications
2
27
0
Order By: Relevance
“…None of differences were found between patients with MDD and healthy individuals. It has been suggested that FAA does not work as a biomarker to differentiate patients with MDD and patients with non-MDD or healthy controls [59]. Some of ndings showed that FAA could be more speci c for treatment response of medication [59,60].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…None of differences were found between patients with MDD and healthy individuals. It has been suggested that FAA does not work as a biomarker to differentiate patients with MDD and patients with non-MDD or healthy controls [59]. Some of ndings showed that FAA could be more speci c for treatment response of medication [59,60].…”
Section: Discussionmentioning
confidence: 99%
“…It has been suggested that FAA does not work as a biomarker to differentiate patients with MDD and patients with non-MDD or healthy controls [59]. Some of ndings showed that FAA could be more speci c for treatment response of medication [59,60]. Furthermore, FAA was involved in the risky trait such as a suicidal behavior or ideation in patients with MDD [58,61].…”
Section: Discussionmentioning
confidence: 99%
“…eLORETA eLORETA analysis demonstrated that responders compared to nonresponders, had significantly lower alpha-2 sources in the frontal lobe [Brodmann area (BA) 6, 8, 9, 32, 44, 45, 46], limbic lobe (BA 24,33), and the insula (BA 13) ( Figure 2 and Table 2). Similarly, responders showed significantly lower beta-1 current densities in the frontal lobe (BA 6, 8, 9, 44), limbic lobe (BA 24), and the insula (BA 13) ( Figure 3 and Table 3).…”
Section: Spectral Power and Asymmetrymentioning
confidence: 99%
“…A recent study showed that patients responding to treatment with escitalopram exhibited elevated absolute alpha power in their left hemisphere while non-responders demonstrated the opposite (23). Greater right frontal alpha is associated with response to escitalopram and sertraline, but only for females (24,25) while less alpha current source density in posterior areas has been associated with nonresponse in unmedicated depressed patients (26,27). Moreover, successful antidepressant treatment of patients with more severe depression is accompanied by an increase in the left DLPFC and amygdala upper alpha EEG activity (28).…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, while participants in the original dataset (Bailey et al, 2019) were mostly taking antidepressants (and also mood stabilizers or antidepressants, or no medications in a small number of cases), the replication dataset Chapter 2) was a naturalistic sample so did not obtain verified data on medication use. However, recent research examining frontal alpha asymmetry has shown the measure could accurately predict response both prior to and after SSRI treatment, suggesting that successful prediction of treatment response with EEG measures is likely to be robust to differences in medication status (van der Vinne, Vollebregt, van Putten, & Arns, 2019). Lastly, the two samples measured depression severity (and as such defined response to treatment) using different scales.…”
Section: Discussionmentioning
confidence: 99%